HansBiomed Corporation (042520) — Capital Reinvestment Ratio
HansBiomed Corporation (042520) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.21 Billion) in capital expenditures (₩448.85 Million). See 042520 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
HansBiomed Corporation Capital Reinvestment Ratio (2012–2025)
This chart tracks HansBiomed Corporation's Capital Reinvestment Ratio across 10 annual periods. Check total reinvestment intensity of HansBiomed Corporation to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for HansBiomed Corporation (2012–2025)
Year-by-year Capital Reinvestment Ratio for HansBiomed Corporation from 2012 to 2025. For live market cap and broader valuation context, see HansBiomed Corporation (042520) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 5.52x | ₩318.34 Million | ₩1.76 Billion | ▲ +243.2% |
| 2024 | 1.61x | ₩1.76 Billion | ₩2.83 Billion | ▲ +31.3% |
| 2020 | 1.23x | ₩5.75 Billion | ₩7.05 Billion | ▼ -39.3% |
| 2019 | 2.02x | ₩7.71 Billion | ₩15.56 Billion | ▲ +368.7% |
| 2018 | 0.43x | ₩5.20 Billion | ₩2.24 Billion | ▼ -81.5% |
| 2017 | 2.33x | ₩5.60 Billion | ₩13.05 Billion | ▲ +33.1% |
| 2015 | 1.75x | ₩3.47 Billion | ₩6.07 Billion | ▼ -70.9% |
| 2014 | 6.01x | ₩2.06 Billion | ₩12.39 Billion | ▲ +92.3% |
| 2013 | 3.13x | ₩2.33 Billion | ₩7.29 Billion | ▲ +1750.5% |
| 2012 | 0.17x | ₩1.50 Billion | ₩253.56 Million | — |